Effects of pirenzepine on pupil size and accommodation in rhesus monkeys

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 10, 2004, Pages 3620-3628

  Ostrin, Lisa A ^a   Frishman, Laura J ^a   Glasser, Adrian ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CARBACHOL; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE;

ACCOMMODATION; ACCOMMODATION PARALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; EDINGER WESTPHAL NUCLEUS; ELECTRODE; EYE REFRACTION; HYPERMETROPIA; MESENCEPHALON; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PUPIL; RHESUS MONKEY;

ACCOMMODATION, OCULAR; ANIMALS; CARBACHOL; CONJUNCTIVA; ELECTRODES, IMPLANTED; INJECTIONS; MACACA MULATTA; MICROELECTRODES; MUSCARINIC ANTAGONISTS; OPHTHALMIC SOLUTIONS; PIRENZEPINE; PUPIL; REFRACTION, OCULAR;

EID: 4644292279     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0258     Document Type: Article

References (40)

1. Collison DJ, Coleman RA, James RS, et al. Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci. 2000;41:2633-2641.
2. Caulfield M, Birdsall N. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998;50:279-290.
3. Leech EM, Cottriall CL, McBrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthalmic Physiol Opt. 1995;15:351-356.
4. Cottriall CL, McBrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci. 1996;37:1368-1379.
5. Tigges M, Iuvone P, Fernandes A, et al. Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci. 1999;76:397-407.
6. McBrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci. 1993;34:205-215.
7. Truong H, Cottriall CL, Gentle A, McBrien NA. Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. Exp Eye Res. 2002;74:103-111.
8. Stacher G, Havlik E, Bergmann H, et al. Effects of oral pirenzepine on gastric emptying and antral motor activity in healthy man. Scand J Gastroenterol Suppl. 1982;72:153-158.
9. Bartlett JD, Niemann K, Houde B, et al. A tolerability study of pirenzepine ophthalmic gel in myopic children. J Ocul Pharmacol Ther. 2003;19:271-279.
10. Chiang MF, Kouzis A, Pointer RW, Repka MX. Treatment of childhood myopia with atropine eye drops and bifocal spectacles. Binocul Vis Strabismus Q. 2001;16:209-215.
11. Syniuta LA, Isenberg SJ. Atropine and bifocals can slow the progression of myopia in children. Binocul Vis Strabismus Q. 2001;16:203-208.
12. Woldemussie E, Feldmann BJ, Chen J. Characterization of muscarinic receptors in cultured human iris sphincter and ciliary smooth muscle cells. Exp Eye Res. 1993;56:385-392.
13. Poyer JF, Gabelt BT, Kaufman PL. The effect of muscarinic agonists and selective receptor subtype antagonists on the contractile response of the isolated rhesus monkey ciliary muscle. Exp Eye Res. 1994;59:729-736.
14. Gabelt BT, Kaufman PL. Inhibition of outflow facility and accommodative and miotic responses to pilocarpine in rhesus monkeys by muscarinic receptor subtype antagonists. J Pharmacol Exp Ther. 1992;263:1133-1139.
15. Gabelt BT, Kaufman PL. Inhibition of aceclidine-stimulated outflow facility, accommodation and miosis in rhesus monkeys by muscarinic receptor subtype antagonists. Exp Eye Res. 1994;58:623-30.
16. Pang I-H, Matsumoto S, Tamm E, DeSantis L. Characterization of muscarinic receptor involvement in human ciliary muscle cell function. J Ocul Pharmacol. 1994;10:125-136.
17. Rickers M, Schaeffel F. Dose-dependent effects of intravitreal pirenzepine on deprivation myopia and lens-induced refractive errors in chickens (letter). Exp Eye Res. 1995;61:509-516.
18. Cottriall CL, McBrien NA, Annies R, Leech EM. Prevention of form-deprivation myopia with pirenzepine: a study of drug delivery and distribution. Ophthalmic Physiol Opt. 1999;19:327-335.
19. Stone RA, Lin T, Laties AM. Muscarinic antagonist effects on experimental chick myopia (letter). Exp Eye Res. 1991;52:755-758.
20. Koretz JF, Bertasso AM, Neider MW, et al. Slit-lamp studies of the rhesus monkey eye. II Changes in crystalline lens shape, thickness and position during accommodation and aging. Exp Eye Res. 1987;45:317-326.
21. Bito LZ, DeRousseau CJ, Kaufman PL, Bito JW. Age-dependent loss of accommodative amplitude in rhesus monkeys: an animal model for presbyopia. Invest Ophthalmol Vis Sci. 1982;23:23-31.
22. Tornqvist G. Effect of topical carbachol on the pupil and refraction in young and presbyopic monkeys. Invest Ophthalmol Vis Sci. 1966;5:186-195.
23. Glasser A, Kaufman PL. The mechanism of accommodation in primates. Ophthalmology. 1999;106:863-872.
24. Koretz JF, Neider MW, Kaufman PL, et al. Slit-lamp studies of the rhesus monkey eye. I. Survey of the anterior segment. Exp Eye Res. 1987;44:307-318.
25. Kaufman PL. Anticholinesterase-induced cholinergic subsensitivity in primate accommodative mechanism. Am J Ophthalmol. 1978;85:622-631.
26. Crawford K, Terasawa E, Kaufman PL. Reproducible stimulation of ciliary muscle contraction in the cynomolgus monkey via a permanent indwelling midbrain electrode. Brain Res. 1989;503:265-272.
27. Croft MA, Kaufman PL, Erickson-Lamy K, Polansky JR. Accommodation and ciliary muscle muscarinic receptors after echothiophate. Invest Ophthalmol Vis Sci. 1991;32:3288-3297.
28. Vilupuru AS, Glasser A. Dynamic accommodation in rhesus monkeys. Vision Res. 2002;42:125-141.
29. Ostrin LA, Glasser A. The effects of phenylephrine on pupil diameter and accommodation in rhesus monkeys. Invest Ophthalmol Vis Sci. 2004;45:215-221.
30. Fincham EF. The coincidence optometer. Proc Phys Soc (London). 1937;49:456-468.
31. Kaufman PL, Lütjen-Drecoll E. Total iridectomy in the primate in vivo: surgical technique and postoperative anatomy. Invest Ophthalmol Vis Sci. 1975;14:766-771.
32. Vilupuru AS, Glasser A. Dynamic accommodative changes in Rhesus monkey eyes assessed with A-scan ultrasound biometry. Optom Vis Sci. 2003;80:383-394.
33. Bito LZ, Kaufman PL, DeRousseau CJ, Koretz J. Presbyopia: an animal model and experimental approaches for the study of the mechanism of accommodation and ocular aging. Eye. 1987;1:222-230.
34. Crawford KS, Kaufman PL, Bito LZ. The role of the iris in accommodation of rhesus monkeys. Invest Ophthalmol Vis Sci. 1990;31:2185-2190.
35. Masuda H, Goto M, Tamaoki S, et al. M3-type muscarinic receptors predominantly mediate neurogenic quick contraction of bovine ciliary muscle. Gen Pharmocol. 1998;30:579-584.
36. Choppin A, Eglen R. Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle. Br J Pharmacol. 2001;132:835-842.
37. Ishikawa H, DeSantis L, Patil PN. Selectivity of muscarinic agonists including (+/-)-aceclidine and antimuscarinics on the human intraocular muscles. J Ocul Pharmacol Ther. 1998;14:363-373.
38. Crawford K, Gabelt BT, Kaufman PL, Bito LZ. Effects of various anesthetic and autonomic drugs on refraction in monkeys. Curr Eye Res. 1990;9:525-532.
39. Bartlett JD, Jaanus SD, Fiscella RG, Sharir M. Ocular hypotensive drugs. In: Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmacology. 4th ed. Woburn, MA: Butterworth-Heinemann, 2001;chap. 10.
40. Poyer JF, Kaufman PL, Flugel C. Age does not affect contractile responses of the isolated rhesus monkey ciliary muscle to muscarinic agonists. Curr Eye Res. 1993;12:413-422.